Blogs about: Policy Ethics
Featured Blog
New European Hypertension Guidelines Released With Simplified Blood Pressure Target
New hypertension guidelines from the European Society of Hypertension and the European Society of Cardiology were released in Milan today at the European Meeting on Hypertension & Cardiovascular P… more →
CardioBrief
New European Hypertension Guidelines Released With Simplified Blood Pressure Target
— 1 comment
wrote 3 days ago: New hypertension guidelines from the European Society of Hypertension and the European Society of Ca … more →
New Trend? Free Tablet Computers For All Registrants At TCT Meeting
wrote 4 days ago: Cardiologists and others who attend this year’s TCT meeting in San Francisco will receive a fr … more →
Study Finds More Musculoskeletal Problems In People Who Take Statins
wrote 1 week ago: An observational study published in JAMA Internal Medicine provides new evidence suggesting that peo … more →
With One Big Exception FDA Reviewers Back More Benign View Of Avandia Trial
wrote 2 weeks ago: The FDA today released a 538-page briefing document for an advisory panel meeting on Wednesda … more →
A CME Program Begs The Question: Promotion Or Education?
wrote 2 weeks ago: In recent years defenders of commercially-supported continuing medical education (CME) have claimed … more →
Two FDA Officials Quarrel Over Safety Of Angiotensin Receptor Blockers
— 1 comment
wrote 2 weeks ago: Two FDA officials are quarreling in public about their different views about the safety of angiotens … more →
Independent Re-Adjudication Of RECORD Confirms Safety Of Rosiglitazone
wrote 2 weeks ago: An independent re-adjudication of the RECORD trial has confirmed the original findings of the trial, … more →
Rivaroxaban Gains Approval In Europe For ACS Indication
wrote 3 weeks ago: Rivaroxaban (Xarelto, Bayer) has been approved in Europe for the prevention of atherothrombotic even … more →
Spinning RECORD: Battle Over Rosiglitazone Heats Up Two Weeks Before Crucial FDA Meeting
— 1 comment
wrote 3 weeks ago: Battle lines are being drawn two weeks before a highly unusual two-day FDA advisory committee meetin … more →
Novartis Acknowledges Employees Participated In 'Independent' Trials
wrote 3 weeks ago: Novartis has acknowledged that employees of the company participated in five “independent … more →
Small Study Suggests Statins May Blunt Benefits Of Exercise
— 1 comment
wrote 3 weeks ago: A small study is raising big questions about whether statins may blunt the beneficial effects of exe … more →
Athletes With Defibrillators Don't Need To Quit Sports
wrote 3 weeks ago: Although the American College of Cardiology and the European Society of Cardiology now advise people … more →
European Medicines Agency Starts Review of Combined Use Of Drugs That Block The Renin-Angiotensin System
— 1 comment
wrote 4 weeks ago: The European Medicines Agency said last week that it was initiating a review of the combined use of … more →
Similar Cardiovascular Risk Observed With COPD Drugs
wrote 4 weeks ago: A large observational study has found no difference in the increased risk for cardiovascular disea … more →
Salt Report From IOM Sparks Much Heat, Only A Little Light
wrote 1 month ago: An Institute of Medicine report on salt earlier this week sparked a lot of controversy. The report c … more →
Our Limitless Capacity For Self-Deception
— 10 comments
wrote 1 month ago: I want to share with my readers a recent post and accompanying comment published on CardioExchange. … more →
Suspicions Raised About Another Japanese Cardiovascular Researcher
wrote 1 month ago: Significant questions about research misconduct have been raised about a prominent Japanese cardiova … more →
Encouraging 4 Year Results For Watchman Device In AF Patients
wrote 1 month ago: Encouraging long-term results from the PROTECT AF trial comparing the Watchman left atrial appendage … more →
FDA Approves Combination Of Ezetimibe And Atorvastatin
wrote 1 month ago: The FDA has approved a new combination drug from Merck for lowering cholesterol. The drug, which wil … more →
